Teva Pharmaceutical Industries Limited
USD33.08
-1.56 (-4.50%)
CEO
Richard D. Francis
IPO Date
1982-02-16
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NYSE
Country
IL
Open
$34.15
Prev. Close
$34.64
Day Low
$32.51
Day High
$34.15
52W Low
$14.99
52W High
$37.35
Market Cap
$38.52B
Volume
10.26M
| 7,242 |
| $0.00 |
| 1 Jun 2026 | Nisen Perry | director | A-Award | Acquired | 7,242 | $0.00 |
| 1 Jun 2026 | LIEBERMAN GERALD M | director | A-Award | Acquired | 7,242 | $0.00 |
| 1 Jun 2026 | Elstein Amir | director | A-Award | Acquired | 7,242 | $0.00 |
| 1 Jun 2026 | Crane Rosemary A | director | A-Award | Acquired | 7,242 | $0.00 |
| 1 Jun 2026 | Lichtenstein Chen | director | A-Award | Acquired | 7,242 | $0.00 |
| 1 Jun 2026 | BARER SOL J | director | A-Award | Acquired | 10,863 | $0.00 |
| 1 Jun 2026 | MIGNONE ROBERTO | director | A-Award | Acquired | 7,242 | $0.00 |
| 18 May 2026 | Lippman Evan | EVP, Business Development | M-Exempt | Acquired | 11,841 | $0.00 |
| Disclosed | Representative | Office | Type | Amount |
|---|---|---|---|---|
| 2 Dec 2020 | Greg Gianforte | Greg Gianforte | Purchase | $15,001 - $50,000 |
| 15 May 2020 | Donna Shalala | Donna Shalala | Sale (Full) | $1,001 - $15,000 |
| 11 Jul 2019 | David E. Price | David E. Price | Sale (Full) | $1,001 - $15,000 |